The UK Government has pledged on Apr. 16 £1.5 million to fund a new FemTech healthcare challenge aimed at supporting NHS systems in working with FemTech developers to address unmet needs, particularly focusing on community service models and health inequalities.
This funding is part of the recently published Women’s Health Strategy, which aims to encourage innovation in women’s health technology and improve access across the NHS. The initiative is intended to help the NHS purchase products and free up clinical and management capacity so that new ways of working can be adopted for the benefit of women’s health.
According to Chris Whitehouse, a political consultant and expert on medical technology policy at Whitehouse Communications, "the commitment to encourage FemTech" is central to the government’s strategy. The plan includes evaluating examples from funded projects, which will help developers gather evidence needed for broader adoption within the NHS.
The Strategy states that government will "direct and deploy technology to benefit all women," noting recent growth in technologies targeting women's health. It also pledges improvements in collaboration between NICE (National Institute for Health and Care Excellence) and the Medicines and Healthcare products Regulatory Agency, aiming for faster access so innovations can be more easily adopted by healthcare providers.
Additional measures include launching a National HealthTech Access Programme and an innovator passport designed to reduce barriers for proven technologies spreading throughout the NHS. However, challenges remain due to limited mature evidence among current products—a gap this new challenge seeks to address.
The Strategy warns that much of today’s market consists of direct-to-consumer or wellness-branded products, raising concerns that these may not target unmet clinical needs or could worsen health inequalities if not properly directed. The government says it intends "to act to direct and support development and deployment so that FemTech supports the shift from hospitals to communities," addressing both clinical challenges in women’s health and existing disparities.
